Overview

Vancomycin Dosage Strategy Based on a Trough Concentration Model

Status:
Recruiting

Trial end date:
2021-12-31

Target enrollment:

Participant gender:

Summary

Study design: Allocation: Randomized Endpoint classification: Efficacy study Masking: Open label Primary purpose: Treatment Primary endpoint: Incidence of reaching the target serum trough concentration Secondary endpoint: Clinical efficiency, Antibiotic use, acute kidney injury.

Phase:

Phase 4

Details

Lead Sponsor:

Peking University Third Hospital

Treatments:

Vancomycin